Colombian-American integrative physician. He also spent years working and living in the Peruvian Amazon at the traditional healing center Nihue Rao Centro Espiritual, training there as an Ayahuasquero. He is the author of books The Fellowship of the River and Medicine Song. With his spiritual community in Phoenix, Dr. Tafur co-founded the Church of the Eagle and the Condor (CEC). He guest lectures on psychedelic medicine at the University of Arizona School of Medicine. Dr. Tafur is also a co-founder of the nonprofit Modern Spirit, dedicated to demonstrating the value of spiritual healing in modern healthcare.

Founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS). His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist.

Psychiatrist based in San Juan, PR, specializing in child and adolescent psychiatry. She completed her medical education and training at the University of Puerto Rico, with a residency in psychiatry and a fellowship in child and adolescent psychiatry and a postdoctoral master's in clinical and translational research. Her expertise includes anxiety disorders, obsessive compulsive disorder, autism spectrum disorders, ADHD, and general psychiatry. She has contributed to several publications, including works on climate change's impact on health, health disparities, and genomic studies related to OCD. Dr. Martinez-Gonzalez also investigates innovative treatment approaches, such as the role of yoga therapy in addressing oppositional defiant disorder behaviors and addressing perinatal mental health to improve pediatric mental health.

David Sunday is a United States Air Force veteran, nonprofit executive, and nationally recognized recovery advocate dedicated to helping veterans and underserved communities heal from trauma and addiction.

With more than a decade of leadership in recovery services, community engagement, and trauma-informed wellness, he has led veteran-focused initiatives, facilitated mind-body medicine programs, and built strategic partnerships across the United States. A recipient of the 2024 Presidential Volunteer Service Award and the 2019 Veteran of the Year Award from the Michael E. DeBakey VA Medical Center, David now serves as a powerful voice for veteran healing and recovery, sharing his personal experience with ibogaine and its transformative potential.

Mike Mumola is a founding law firm partner, trial attorney, strategic advisor, and recognized leader in psychedelic law and policy. With more than two decades of legal experience, he advises family offices, entrepreneurs, investors, and mission-driven organizations on governance, emerging markets, and long-term strategy. A member of the National Psychedelic Bar Association, Mike has contributed to initiatives advancing ethical psychedelic reform across the United States and Latin America, including the Texas Ibogaine Initiative and early support for Americans for Ibogaine. His work bridges law, policy, investment, science, and indigenous wisdom to help shape responsible pathways for the future of psychedelic medicine.

Dr. Martín Polanco is a physician with over two decades of expertise in functional and psychedelic-assisted therapies, with a specialization in ibogaine and 5-MeO-DMT. As the founder of The Mission Within and the earlier Crossroads Treatment Center, he has treated more than 5,000 patients, including over 1,300 Special Operations veterans and their families for complex, treatment-resistant conditions including PTSD, mild traumatic brain injury (mTBI), depression, and substance use disorder. His clinical work has been conducted at treatment facilities in northern Mexico and Costa Rica, and he is a recognized pioneer in translating psychedelic medicine from emerging research into structured, medically rigorous clinical programs. His mission is to make ibogaine and 5-MeO-DMT therapy accessible to every veteran in need, and to build the evidence base required for legalization.

Chief Executive Officer and Co-Founder of Ambio Life Sciences. One of the world's leading experts on ibogaine, Jonathan brings over 15 years of experience in clinical care, traditional practice, and psychedelic research to his leadership at Ambio. A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, he authored the field's foundational safety guidelines and has published widely on ibogaine's therapeutic, cultural, and ecological significance. He holds the first active export license for Tabernanthe iboga root, led the first Nagoya-compliant export from Gabon, and was initiated into the Dissoumba/Fang tradition of Bwiti in 2014 and the Missoko tradition in 2022. He has co-authored peer-reviewed research on ibogaine's potential for people with trauma, TBI, pain, MS, and Parkinson's. His 2026 book, Ibogaine and the Bicameral Mind, is a groundbreaking work of literary non-fiction that explores the cultural, scientific, and philosophical dimensions of one of the world's most enigmatic psychoactive substances. At Ambio, he leads strategy, research, and innovation—advancing a globally scalable model of care that bridges tradition, science, and integrity.

An attorney specializing in the regulatory, health care, business, and religious freedom aspects of psychedelic medicines and therapies in the United States. His work has included: Advising doctors, therapists and licensed professionals on psychedelic assisted therapy (typically ketamine), including defense of licensure in disciplinary proceedings; Advising clients on religious exemptions for the use of psychedelics, including being a lawyer for the Church of the Eagle and the Condor and the Church of the Celestial Heart who received formal recognition from the US government to operate ayahuasca churches in the United States; Drafter of Colorado's Natural Medicine Health Act legalizing four psychedelics in that state; Denver Psilocybin Mushroom Policy Review Panel member; General Counsel for the Zendo Project; Advisory Board member for Psychedelic Parenthood Community; and outside general counsel to MAPS Psychedelic Science Events, LLC. Sean is licensed to practice law in Colorado and California, but consults all across the US on religious freedom issues.

An integrative psychiatrist, researcher, educator, and advocate advancing the responsible integration of psychedelic medicine into mental health care in Puerto Rico. She is the Co-Founder and Chief Medical Officer of Sattva Clinic and Director of Education & Research at Pravan Foundation, where she leads clinical education, research, and professional training to expand access to innovative mental health care. Dr. Rullán is the Principal Investigator of Puerto Rico's first randomized clinical trial evaluating esketamine with psychedelic preparation and integration for treatment-resistant depression and is a Faculty Fellow of the Usona Psychedelic Education Program (U-PEP), helping advance the integration of psychedelic medicine into physician and psychiatry residency education. Believing that the future of psychiatry lies at the intersection of rigorous science, compassionate relationships, and whole-person care, Dr. Rullán is helping build the next generation of psychedelic care in Puerto Rico while advancing a safe, ethical, and culturally grounded ecosystem for the field.

Clinical Assistant Professor at the Stanford School of Medicine, where she practices clinically as a neuropsychologist. She completed her postdoctoral fellowship in 2023 with the Stanford Brain Stimulation Lab where she led a study for PI, Nolan Williams, MD, examining the effect of ibogaine on the sequelae of TBI and combat in Special Forces Veterans. In addition to her clinical practice, she is involved in research, including investigations of the use of psychedelics to treat TBI, PTSD, depression, and neurocognitive dysfunction. Research interests include the neurological and neurocognitive effects of psychedelics and neuromodulation.

Susan Samueli Endowed Chair and Professor in the Susan Samueli Integrative Health Institute and also a Professor in the Department of Anesthesiology and Perioperative Care in the School of Medicine at the University of California at Irvine. His background is in basic science and clinical research in alternative medicine. He received his B.S. degree in Genetics from Purdue University in 1992 and his Ph.D. in Molecular and Cell Biology from UC Berkeley in 1997. Following his graduate work, he completed a postdoctoral fellowship at NIH. He is a graduate of the Maryland Institute of Traditional Chinese Medicine and has received an MS degree in Clinical Research Design and Statistical Analysis at the University of Michigan. Dr. Harris is currently investigating mechanisms of chronic pain and its treatment with acupuncture and shamanism. His recent investigations have focused on the role of brain neurotransmitters and brain network behavior in chronic pain. He was a member of the National Advisory Council for NIH/NCCIH and is a current co-President for the Society for Acupuncture Research.

A social-entrepreneur who has played a role in advancing the psychedelic movement for well over a decade. He is co-founder of Ambio Life Sciences, the global leader in integrative ibogaine treatments. He is a co-founder of the Canadian Psychedelic Association and from 2018 to 2021 was on the board of directors for the Multidisciplinary Association of Psychedelic Studies (MAPS) Canada, where he acted as Chair of the Board for over two years. Trevor was featured in the award-winning documentary about using magic mushrooms and Iboga to treat addiction, anxiety, and depression called DOSED, which was released in 2019. He is also featured in the documentary In Waves and War following three US Special Forces veterans' journey to healing using ibogaine.

Florida and Puerto Rico-licensed attorney, born and raised in San Juan and based out of Miami, having completed his bachelor's degree at Harvard and his JD at the University of Puerto Rico. His practice spans business law, commercial litigation and arbitration, and psychedelic law and policy. Raúl is about to receive his Certification in Psychedelic-Assisted Therapies and Research from the California Institute of Integral Studies. He serves as Legal & Policy Affairs Advisor and outside General Counsel to the Pravan Foundation, a Puerto Rico–based nonprofit at the forefront of integrative medicine and mental health.

A pivotal figure in building the foundational infrastructure for integrating psychedelic-assisted therapy into the U.S. healthcare system. A family therapist (MFT) and CIIS-certified psychedelic practitioner (CPTR) with 15+ years inside the commercial health-insurance industry—expertise in launching new behavioral-health specialties and securing insurance coverage at scale, directly impacting 20 million covered lives and the broader 250-million commercial market.

Internal Medicine physician, healthcare entrepreneur, and medical executive with over a decade of experience delivering personalized, preventive, and longevity-focused care. Co-Founder and Medical Director of Pravan Health Group, where she leads innovative models of concierge primary care, functional medicine, and health optimization. Her clinical approach integrates evidence-based internal medicine with precision diagnostics, lifestyle medicine, metabolic optimization, hormone therapy, and emerging longevity technologies to improve healthspan and patient outcomes. She is passionate about transforming healthcare through proactive, patient-centered medicine while developing scalable systems that combine clinical excellence with innovation.